Hochschulschrift
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Mainz, Univ., Diss., 2013
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Mainz
- (wer)
-
Universitätsbibliothek Mainz
- (wann)
-
2013
- Urheber
- URN
-
urn:nbn:de:hebis:77-35275
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Reuter, Anika
- Universitätsbibliothek Mainz
Entstanden
- 2013
Ähnliche Objekte (12)
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Studies on the physicochemical stability of antibody conjugates
Multivalent Dendritic Polyglycerol Anions for Diagnostic and Therapeutic Applications
Antibody–drug conjugates as an emerging therapy in oncodermatology
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Studies on the physicochemical stability of antibody conjugates
Multivalent Dendritic Polyglycerol Anions for Diagnostic and Therapeutic Applications
Antibody–drug conjugates as an emerging therapy in oncodermatology
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Studies on the physicochemical stability of antibody conjugates
Multivalent Dendritic Polyglycerol Anions for Diagnostic and Therapeutic Applications
Antibody–drug conjugates as an emerging therapy in oncodermatology
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Essential and complementary function of dendritic cell subsets during immunotherapy
Design and generation of antibody-drug conjugates using non-canonical amino acids